Mario Filion

1.4k total citations
31 papers, 1.2k citations indexed

About

Mario Filion is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Mario Filion has authored 31 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 11 papers in Immunology and 7 papers in Oncology. Recurrent topics in Mario Filion's work include Immune Response and Inflammation (6 papers), RNA Interference and Gene Delivery (5 papers) and Immune Cell Function and Interaction (4 papers). Mario Filion is often cited by papers focused on Immune Response and Inflammation (6 papers), RNA Interference and Gene Delivery (5 papers) and Immune Cell Function and Interaction (4 papers). Mario Filion collaborates with scholars based in Canada, United States and Belgium. Mario Filion's co-authors include Nigel C. Phillips, Francine Décary, Pierre Chartrand, Mindy Goldman, Majid Belouchi, Pierre Chagnon, D. Gauvreau, Yves Robitaille, Dana V. Devine and Lambert Busque and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Mario Filion

31 papers receiving 1.1k citations

Peers

Mario Filion
Louise Collins United Kingdom
Peter Bugert Germany
Karen Pepper United States
M. Nedim Ince United States
Mrinmoy Sanyal United States
Louise Collins United Kingdom
Mario Filion
Citations per year, relative to Mario Filion Mario Filion (= 1×) peers Louise Collins

Countries citing papers authored by Mario Filion

Since Specialization
Citations

This map shows the geographic impact of Mario Filion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Filion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Filion more than expected).

Fields of papers citing papers by Mario Filion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Filion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Filion. The network helps show where Mario Filion may publish in the future.

Co-authorship network of co-authors of Mario Filion

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Filion. A scholar is included among the top collaborators of Mario Filion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Filion. Mario Filion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blais, Normand, Catherine Labbé, Louis Gaboury, et al.. (2024). A phase II trial to evaluate the epithelial-to-mesenchymal (EMT) inhibitor sotevtamab combined with docetaxel in patients with metastatic non-small cell lung cancer following failure of primary chemoimmunotherapy.. Journal of Clinical Oncology. 42(16_suppl). 8577–8577. 1 indexed citations
2.
Stuible, Matthew, et al.. (2014). Mechanism and Function of Monoclonal Antibodies Targeting Siglec-15 for Therapeutic Inhibition of Osteoclastic Bone Resorption. Journal of Biological Chemistry. 289(10). 6498–6512. 62 indexed citations
3.
Tremblay, Gilles, Suzanne Grothé, Sophie Roy, et al.. (2010). Abstract 1467: AB-16B5, a therapeutic monoclonal antibody against human clusterin that blocks the epithelial-to-mesenchymal transition. Cancer Research. 70(8_Supplement). 1467–1467. 2 indexed citations
4.
Filion, Mario, et al.. (2004). Development of immunomodulatory six base-length non-CpG motif oligonucleotides for cancer vaccination. Vaccine. 22(19). 2480–2488. 5 indexed citations
5.
Filion, Mario, et al.. (2003). Development of short non-CpG phosphodiester oligonucleotides as immune stimulatory agents. Vaccine. 21(9-10). 983–989. 13 indexed citations
6.
Ménard, S., et al.. (2001). Pro‐apoptotic and immunomodulatory activity of a mycobacterial cell wall‐DNA complex towards LNCaP prostate cancer cells. The Prostate. 49(3). 155–165. 10 indexed citations
7.
Filion, Mario, et al.. (2000). Modulation of interleukin-12 synthesis by DNA lacking the CpG motif and present in a mycobacterial cell wall complex. Cancer Immunology Immunotherapy. 49(6). 325–334. 27 indexed citations
9.
Feoli‐Fonseca, Juan Carlos, Luc L. Oligny, Mario Filion, et al.. (1998). JC9813—A Putative Novel Human Papillomavirus Identified by PCR-DS. Biochemical and Biophysical Research Communications. 250(1). 63–67. 14 indexed citations
10.
Feoli‐Fonseca, Juan Carlos, Luc L. Oligny, Mario Filion, et al.. (1998). Direct Human Papillomavirus (HPV) Sequencing Method Yields a Novel HPV in a Human Immunodeficiency Virus–Positive Quebec Woman and Distinguishes a New HPV Clade. The Journal of Infectious Diseases. 178(5). 1492–1496. 16 indexed citations
11.
Filion, Mario & Nigel C. Phillips. (1998). Major limitations in the use of cationic liposomes for DNA delivery. International Journal of Pharmaceutics. 162(1-2). 159–170. 126 indexed citations
12.
Filion, Mario & Nigel C. Phillips. (1997). Toxicity and immunomodulatory activity of liposomal vectors formulated with cationic lipids toward immune effector cells. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1329(2). 345–356. 340 indexed citations
13.
Filion, Mario & Nigel C. Phillips. (1997). Anti‐inflammatory activity of cationic lipids. British Journal of Pharmacology. 122(3). 551–557. 55 indexed citations
14.
Bertrand, Richard, M. Beauchemin, Aline Mamo, et al.. (1995). Cloning and characterization of the human 5,10-methenyltetrahydrofolate synthetase-encoding cDNA. Gene. 165(2). 307–311. 24 indexed citations
15.
Goldman, Mindy, et al.. (1994). Neonatal Alloimmune Thrombocytopenia. Transfusion Medicine Reviews. 8(2). 123–131. 20 indexed citations
16.
Filion, Mario, Mindy Goldman, Allan Bradley, et al.. (1994). Analysis of immunoglobulin class, IgG subclass and titre of HPA‐1a antibodies in alloimmunized mothers giving birth to babies with or without neonatal alloimmune thrombocytopenia. British Journal of Haematology. 87(4). 813–817. 45 indexed citations
17.
L’Abbé, Denis, Mario Filion, Lambert Busque, et al.. (1992). Alloimmunization to Platelet antigen HPA-1a (PIA1) is strongly associated with both HLA-DRB3∗0101 and HLA-DQB1∗0201. Human Immunology. 34(2). 107–114. 94 indexed citations
18.
Brandhorst, Bruce P., Mario Filion, Paul E. Nisson, & William R. Crain. (1991). Restricted expression of the Lytechinus pictus Spec1 gene homologue in reciprocal hybrid embryos with Strongylocentrotus purpuratus. Developmental Biology. 144(2). 405–411. 8 indexed citations
19.
Lussier, Marc, Mario Filion, John G. Compton, et al.. (1990). The mouse keratin 19-encoding gene: sequence, structure and chromosomal assignment. Gene. 95(2). 203–213. 29 indexed citations
20.
Filion, Mario, Marc Lussier, André Royal, Christian Gervais, & M. Suh. (1988). Identification of a proliferation-related transcript with an elevated expression in the mid-gestation mouse embryo. Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression. 950(3). 255–262. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026